Overview

A Study of Colesevelam in Fecal Incontinence

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
Compare the effects of a combination of colesevelam and clonidine to placebo on bowel symptoms in patients with urge or combined type of FI.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Clonidine
Colesevelam Hydrochloride